Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr;17(2):e12721.
doi: 10.1111/acel.12721. Epub 2018 Jan 31.

Ablation of PPARγ in subcutaneous fat exacerbates age-associated obesity and metabolic decline

Affiliations

Ablation of PPARγ in subcutaneous fat exacerbates age-associated obesity and metabolic decline

Lingyan Xu et al. Aging Cell. 2018 Apr.

Abstract

It is well established that aging is associated with metabolic dysfunction such as increased adiposity and impaired energy dissipation; however, the transcriptional mechanisms regulating energy balance during late life stages have not yet been fully elucidated. Here, we show that ablation of the nuclear receptor PPARγ specifically in inguinal fat tissue in aging mice is associated with increased fat tissue expansion and insulin resistance. These metabolic effects are accompanied by decreased thermogenesis, reduced levels of brown fat genes, and browning of subcutaneous adipose tissue. Comparative studies of the effects of PPARγ downregulation in young and mid-aged mice demonstrate a preferential regulation of brown fat gene programs in inguinal fat in an age-dependent manner. In conclusion, our study uncovers an essential role for PPARγ in maintaining energy expenditure during the aging process and suggests the possibility of targeting PPARγ to counteract age-associated metabolic dysfunction.

Keywords: PPARγ; aging; metabolic decline; obesity; subcutaneous fat.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Selective ablation of PPARγ in iWAT of aging mice via adenoviral delivery. (a–d) Analysis of 12‐month‐old control, PPARγ‐iWATKO, and PPARγ‐iWATKD mice. = 6 per group. (a) Illustration of the strategy used to achieve modulation of PPARγ levels in iWAT via adenoviral delivery. (b) mRNA and (c) protein levels of PPARγ in iWAT. (d) mRNA levels of PPARγ in fat depots, liver, pancreas, and macrophages present in iWAT. Data are presented as mean ± SEM and *, p < .05; **, p < .01
Figure 2
Figure 2
PPARγ deficiency in iWAT of aging mice increases adiposity. (a–g) Analysis of 12‐month‐old control, PPARγ‐iWATKO, and PPARγ‐iWATKD mice. = 6 per group. (a) Body weight; (b) fat mass; (c) lean mass; (d) adipose tissue weights; (e) tissue weights; (f) representative images of H&E staining of adipose tissues; (g) adipocyte sizes of iWAT and eWAT. Data are presented as mean ± SEM and *, p < .05; **, p < .01
Figure 3
Figure 3
Impaired glucose and lipid homeostasis in aging mice with PPARγ deficiency in iWAT. (a–d) Analysis of 12‐month‐old control, PPARγ‐iWATKO, and PPARγ‐iWATKD mice. = 6 per group. (a, b, c) Insulin sensitivity measured by GTT and ITT and shown as area under the curve (AUC); (d) serum parameters including free fatty acids (FFA), total triglyceride (TG), and total cholesterol (TC). Data are presented as mean ± SEM and *, p < .05; **, p < .01
Figure 4
Figure 4
PPARγ is required for the maintenance of brown fat programs in iWAT of aging mice. (a–e) Analysis of 12‐month‐old control, PPARγ‐iWATKO, and PPARγ‐iWATKD mice. = 6 per group. (a) Oxygen consumption normalized to lean mass (LM); (b) food intake; (c) total locomotor activity; (d) gene expression levels of white and brown markers in iWAT; (e) representative images of UCP1 staining in iWAT. Data are presented as mean ± SEM and *, p < .05; **, p < .01
Figure 5
Figure 5
PPARγ deficiency in iWAT of young and aging mice leads to distinct adiposity phenotypes. (a) Illustration of the strategy used to reduce PPARγ levels in the iWAT of young and aging mice via adenoviral delivery. (b) PPARγ mRNA levels; (c) weight of iWAT; (d) representative H&E images of iWAT and (e) adipocyte area in 2‐month‐old and 12‐month‐old mice injected with shRNA control (shCon) or shPPARγ (shPPARγ) adenoviruses. Data are presented as mean ± SEM and *, p < .05; **, p < .01
Figure 6
Figure 6
PPARγ preferentially regulates brown gene programs in inguinal fat of aging mice. (a) Heat map of white and brown gene transcripts in iWAT of 2‐month‐old (young) and 12‐month‐old (aging) mice with knockdown of PPARγ (shPPARγ) compared to control (shCon) (b, c) White and brown PPARγ gene targets in iWAT of 2‐month‐old (b) and 12‐month‐old (c) mice after PPARγ knockdown. (d) Chromatin IP at the aP2 promoter and at the Ucp1 enhancer in iWAT of 2‐month‐old (Young) and 12‐month‐old (Aging) mice. The β‐globin promoter was used as a negative control. Data are presented as mean ± SEM and *, < .05; **, < .01. = 7–8 per group

Similar articles

Cited by

References

    1. Choi, J. H. , Choi, S. S. , Kim, E. S. , Jedrychowski, M. P. , Yang, Y. R. , Jang, H. J. , … Spiegelman, B. M. (2014). Thrap3 docks on phosphoserine 273 of PPARγ and controls diabetic gene programming. Genes & Development, 28, 2361–2369. - PMC - PubMed
    1. Christensen, K. , Doblhammer, G. , Rau, R. , & Vaupel, J. W. (2009). Ageing populations: the challenges ahead. Lancet, 374, 1196–1208. - PMC - PubMed
    1. Cohen, P. , Levy, J. D. , Zhang, Y. , Frontini, A. , Kolodin, D. P. , Svensson, K. J. , … Wu, J. (2014). Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch. Cell, 156, 304–316. - PMC - PubMed
    1. Farmer, S. R. (2008). Molecular determinants of brown adipocyte formation and function. Genes & Development, 22, 1269–1275. - PMC - PubMed
    1. Gesta, S. , Tseng, Y. H. , & Kahn, C. R. (2007). Developmental origin of fat: tracking obesity to its source. Cell, 131, 242–256. - PubMed

Publication types

LinkOut - more resources

-